JPMorgan Chase & Co. Cuts Stake in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)

JPMorgan Chase & Co. lessened its stake in shares of BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 17.8% in the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 474,376 shares of the biotechnology company’s stock after selling 102,753 shares during the quarter. JPMorgan Chase & Co.’s holdings in BioCryst Pharmaceuticals were worth $3,567,000 as […]